#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma Alveolar proteinosis Craniopharyngioma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Pleomorphic liposarcoma Cardiac sarcoidosis Transplant rejection Immunoglobulin G4 related disease Tuberous sclerosis complex Neonatal alloimmune thrombocytopenia Amyotrophic lateral sclerosis Glomerulonephritis chronic Multifocal motor neuropathy Fragile X syndrome Congenital ectodermal dysplasia More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex – Treatment MELAS syndrome – Basic Information Propionic acidaemia – Trials in Disease Gaucher’s disease type III – Diagnostics Hepatic angiosarcoma Andersen-Tawil syndrome – Diagnostics Hereditary motor and sensory neuropathy – Treatment Congenital nephrogenic diabetes insipidus – Basic Information Vascular malformation Marginal zone lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cobicistat Evencaleucel Protein S Azithromycin Dihydrate Resmetirom D5-Ethyl-Beta-D-Glucuronide Efruxifermin Lamivudine Colistimethate Sodium Ciprofloxacin Crofelemer Rezvilutamide Methionine Everolimus Ptg-Carcik-Cd19 Co-Trimoxazole Azd8630 Pralsetinib Cellulose, Microcrystalline SUMATRIPTAN More therapies…

    Learn about Your Condition

    Acute lymphocytic leukaemia Usher's syndrome Spinal muscular atrophy Rectal adenocarcinoma Renal transplant Tinnitus Giardiasis Head and neck cancer stage IV Asplenia HER2 positive gastric cancer Cardiac amyloidosis Asthma Angiosarcoma Hypersomnia Rhinitis allergic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinički bolnički centar Rijeka (Clinical Hospital…

Klinički bolnički centar Rijeka (Clinical Hospital Center Rijeka)

Kresimirova 42, Rijeka, 51000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Sotagliflozin
    Belgium Bulgaria Croatia Czechia France Germany +7

  • Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Upadacitinib
    • Vedolizumab
    Austria Belgium Croatia Czechia Denmark France +12

  • Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

    Recruiting

    3 1 1
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Navtemadlin
    • Ondansetron
    Austria Belgium Croatia Czechia France Germany +7

  • Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia Denmark Finland +12

  • Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Carbasalate Calcium
    • Enoxaparin Sodium
    • Givinostat
    Austria Bulgaria Croatia France Germany Hungary +5

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Bortezomib
    • Carfilzomib
    • Dexamethasone
    Belgium Croatia Czechia Denmark Finland France +10

  • Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

    Recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Austria Bulgaria Croatia Czechia Germany Greece +9

  • Study on Tranexamic Acid Oral Solution for Preventing Bleeding in Patients on Blood Thinners Undergoing Tooth Extraction

    Recruiting

    3 1
    Investigated Diseases:
    • Gingival bleeding
    • Haemorrhage prophylaxis
    Investigated Drugs:
    • Tranexamic Acid
    Croatia Hungary Romania Spain

  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

    Recruiting

    3 1
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +8
Previous Page
1 2 3 4 … 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!